121 – 130 of 235
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2018
-
Mark
No benefit of ticagrelor pretreatment compared with treatment during percutaneous coronary intervention in patients with ST-segment⇓elevation myocardial infarction undergoing primary percutaneous coronary intervention
(
- Contribution to journal › Article
-
Mark
High time to omit oxygen therapy in ST elevation myocardial infarction
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Longitudinal left ventricular function is globally depressed within a week of STEMI
(
- Contribution to journal › Article
-
Mark
The value of pregnancy complication history for 10-year cardiovascular disease risk prediction in middle-aged women
(
- Contribution to journal › Article
-
Mark
Progressive increase of the Tpeak-Tend interval is associated with ischaemia-induced ventricular fibrillation in a porcine myocardial infarction model
(
- Contribution to journal › Article
-
Mark
Antithrombotic therapy after myocardial infarction in patients with atrial fibrillation undergoing percutaneous coronary intervention
(
- Contribution to journal › Article
-
Mark
Correlation of anteroseptal ST elevation with myocardial infarction territories through cardiovascular magnetic resonance imaging
(
- Contribution to journal › Article
-
Mark
Effects of supplemental oxygen therapy in patients with suspected acute myocardial infarction: A meta-analysis of randomized clinical trials
(
- Contribution to journal › Article
-
Mark
Innate immune mechanisms in myocardial infarction - An update
(
- Contribution to journal › Scientific review
- 2017
-
Mark
Cangrelor in combination with ticagrelor provides consistent and potent P2Y12-inhibition during and after primary percutaneous coronary intervention in real-world patients with ST-segment-elevation myocardial infarction
(
- Contribution to journal › Article